Needle-Free Injection Market Research Report By Application (Vaccination, Insulin Delivery, Pain Management, Hormonal Therapy), By Technology (Jet Injector, Nanoparticle Based Delivery, Laser Powered Injection), By End Use (Hospitals, Home Care, Pharmaceutical Companies), By Dosage Form (Solid, Liquid, Lyophilized) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Overview

1.2. Key Findings

1.3. Market Segmentation

1.4. Competitive Landscape

1.5. Challenges and Opportunities

1.6. Future Outlook

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the study

2.2.1. Research Objective

2.2.2. Assumption

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value chain Analysis

5.2. Porter's Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. NEEDLE-FREE INJECTION MARKET, BY APPLICATION (USD BILLION)

6.1. Vaccination

6.2. Insulin Delivery

6.3. Pain Management

6.4. Hormonal Therapy

7. NEEDLE-FREE INJECTION MARKET, BY TECHNOLOGY (USD BILLION)

7.1. Jet Injector

7.2. Nanoparticle Based Delivery

7.3. Laser Powered Injection

8. NEEDLE-FREE INJECTION MARKET, BY END USE (USD BILLION)

8.1. Hospitals

8.2. Home Care

8.3. Pharmaceutical Companies

9. NEEDLE-FREE INJECTION MARKET, BY DOSAGE FORM (USD BILLION)

9.1. Solid

9.2. Liquid

9.3. Lyophilized

10. NEEDLE-FREE INJECTION MARKET, BY REGIONAL (USD BILLION)

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. UK

10.2.3. France

10.2.4. Russia

10.2.5. Italy

10.2.6. Spain

10.2.7. Rest of Europe

10.3. APAC

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Malaysia

10.3.6. Thailand

10.3.7. Indonesia

10.3.8. Rest of APAC

10.4. South America

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Argentina

10.4.4. Rest of South America

10.5. MEA

10.5.1. GCC Countries

10.5.2. South Africa

10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market share Analysis

11.4. Major Growth Strategy in the Needle-Free Injection Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Needle-Free Injection Market

11.7. Key developments and growth strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales and Operating Income

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Ranfac Corp

12.1.1. Financial Overview

12.1.2. Products Offered

12.1.3. Key Developments

12.1.4. SWOT Analysis

12.1.5. Key Strategies

12.2. Antares Pharma

12.2.1. Financial Overview

12.2.2. Products Offered

12.2.3. Key Developments

12.2.4. SWOT Analysis

12.2.5. Key Strategies

12.3. Delpor

12.3.1. Financial Overview

12.3.2. Products Offered

12.3.3. Key Developments

12.3.4. SWOT Analysis

12.3.5. Key Strategies

12.4. Pall Corporation

12.4.1. Financial Overview

12.4.2. Products Offered

12.4.3. Key Developments

12.4.4. SWOT Analysis

12.4.5. Key Strategies

12.5. National Medical Products

12.5.1. Financial Overview

12.5.2. Products Offered

12.5.3. Key Developments

12.5.4. SWOT Analysis

12.5.5. Key Strategies

12.6. Vaxart

12.6.1. Financial Overview

12.6.2. Products Offered

12.6.3. Key Developments

12.6.4. SWOT Analysis

12.6.5. Key Strategies

12.7. MediPharma

12.7.1. Financial Overview

12.7.2. Products Offered

12.7.3. Key Developments

12.7.4. SWOT Analysis

12.7.5. Key Strategies

12.8. Zogenix

12.8.1. Financial Overview

12.8.2. Products Offered

12.8.3. Key Developments

12.8.4. SWOT Analysis

12.8.5. Key Strategies

12.9. PharmaJet

12.9.1. Financial Overview

12.9.2. Products Offered

12.9.3. Key Developments

12.9.4. SWOT Analysis

12.9.5. Key Strategies

12.10. iGel

12.10.1. Financial Overview

12.10.2. Products Offered

12.10.3. Key Developments

12.10.4. SWOT Analysis

12.10.5. Key Strategies

12.11. Enable Injections

12.11.1. Financial Overview

12.11.2. Products Offered

12.11.3. Key Developments

12.11.4. SWOT Analysis

12.11.5. Key Strategies

12.12. SyringeFree Technologies

12.12.1. Financial Overview

12.12.2. Products Offered

12.12.3. Key Developments

12.12.4. SWOT Analysis

12.12.5. Key Strategies

12.13. Gerresheimer

12.13.1. Financial Overview

12.13.2. Products Offered

12.13.3. Key Developments

12.13.4. SWOT Analysis

12.13.5. Key Strategies

12.14. West Pharmaceutical Services

12.14.1. Financial Overview

12.14.2. Products Offered

12.14.3. Key Developments

12.14.4. SWOT Analysis

12.14.5. Key Strategies

12.15. Injex

12.15.1. Financial Overview

12.15.2. Products Offered

12.15.3. Key Developments

12.15.4. SWOT Analysis

12.15.5. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS

TABLE 2. NORTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 3. NORTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 4. NORTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 5. NORTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 6. NORTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 7. US NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 8. US NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 9. US NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 10. US NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 11. US NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 12. CANADA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 13. CANADA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 14. CANADA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 15. CANADA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 16. CANADA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 17. EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 18. EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 19. EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 20. EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 21. EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 22. GERMANY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 23. GERMANY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 24. GERMANY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 25. GERMANY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 26. GERMANY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 27. UK NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 28. UK NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 29. UK NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 30. UK NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 31. UK NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 32. FRANCE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 33. FRANCE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 34. FRANCE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 35. FRANCE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 36. FRANCE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 37. RUSSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 38. RUSSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 39. RUSSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 40. RUSSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 41. RUSSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 42. ITALY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 43. ITALY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 44. ITALY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 45. ITALY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 46. ITALY NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 47. SPAIN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 48. SPAIN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 49. SPAIN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 50. SPAIN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 51. SPAIN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 52. REST OF EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 53. REST OF EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 54. REST OF EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 55. REST OF EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 56. REST OF EUROPE NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 57. APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 58. APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 59. APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 60. APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 61. APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 62. CHINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 63. CHINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 64. CHINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 65. CHINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 66. CHINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 67. INDIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 68. INDIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 69. INDIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 70. INDIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 71. INDIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 72. JAPAN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 73. JAPAN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 74. JAPAN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 75. JAPAN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 76. JAPAN NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 77. SOUTH KOREA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 78. SOUTH KOREA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 79. SOUTH KOREA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 80. SOUTH KOREA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 81. SOUTH KOREA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 82. MALAYSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 83. MALAYSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 84. MALAYSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 85. MALAYSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 86. MALAYSIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 87. THAILAND NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 88. THAILAND NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 89. THAILAND NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 90. THAILAND NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 91. THAILAND NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 92. INDONESIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 93. INDONESIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 94. INDONESIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 95. INDONESIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 96. INDONESIA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 97. REST OF APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 98. REST OF APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 99. REST OF APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 100. REST OF APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 101. REST OF APAC NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 102. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 103. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 104. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 105. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 106. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 107. BRAZIL NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 108. BRAZIL NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 109. BRAZIL NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 110. BRAZIL NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 111. BRAZIL NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 112. MEXICO NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 113. MEXICO NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 114. MEXICO NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 115. MEXICO NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 116. MEXICO NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 117. ARGENTINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 118. ARGENTINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 119. ARGENTINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 120. ARGENTINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 121. ARGENTINA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 122. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 123. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 124. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 125. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 126. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 127. MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 128. MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 129. MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 130. MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 131. MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 132. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 133. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 134. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 135. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 136. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 137. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 138. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 139. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 140. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 141. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 142. REST OF MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)

TABLE 143. REST OF MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2032 (USD BILLIONS)

TABLE 144. REST OF MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY END USE, 2019-2032 (USD BILLIONS)

TABLE 145. REST OF MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)

TABLE 146. REST OF MEA NEEDLE-FREE INJECTION MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)

TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL

TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS

FIGURE 2. NORTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS

FIGURE 3. US NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 4. US NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 5. US NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 6. US NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 7. US NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 8. CANADA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 9. CANADA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 10. CANADA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 11. CANADA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 12. CANADA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 13. EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS

FIGURE 14. GERMANY NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 15. GERMANY NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 16. GERMANY NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 17. GERMANY NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 18. GERMANY NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 19. UK NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 20. UK NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 21. UK NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 22. UK NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 23. UK NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 24. FRANCE NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 25. FRANCE NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 26. FRANCE NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 27. FRANCE NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 28. FRANCE NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 29. RUSSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 30. RUSSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 31. RUSSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 32. RUSSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 33. RUSSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 34. ITALY NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 35. ITALY NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 36. ITALY NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 37. ITALY NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 38. ITALY NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 39. SPAIN NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 40. SPAIN NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 41. SPAIN NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 42. SPAIN NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 43. SPAIN NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 44. REST OF EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 45. REST OF EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 46. REST OF EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 47. REST OF EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 48. REST OF EUROPE NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 49. APAC NEEDLE-FREE INJECTION MARKET ANALYSIS

FIGURE 50. CHINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 51. CHINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 52. CHINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 53. CHINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 54. CHINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 55. INDIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 56. INDIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 57. INDIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 58. INDIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 59. INDIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 60. JAPAN NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 61. JAPAN NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 62. JAPAN NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 63. JAPAN NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 64. JAPAN NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 65. SOUTH KOREA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 66. SOUTH KOREA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 67. SOUTH KOREA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 68. SOUTH KOREA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 69. SOUTH KOREA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 70. MALAYSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 71. MALAYSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 72. MALAYSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 73. MALAYSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 74. MALAYSIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 75. THAILAND NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 76. THAILAND NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 77. THAILAND NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 78. THAILAND NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 79. THAILAND NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 80. INDONESIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 81. INDONESIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 82. INDONESIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 83. INDONESIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 84. INDONESIA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 85. REST OF APAC NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 86. REST OF APAC NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 87. REST OF APAC NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 88. REST OF APAC NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 89. REST OF APAC NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 90. SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS

FIGURE 91. BRAZIL NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 92. BRAZIL NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 93. BRAZIL NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 94. BRAZIL NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 95. BRAZIL NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 96. MEXICO NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 97. MEXICO NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 98. MEXICO NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 99. MEXICO NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 100. MEXICO NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 101. ARGENTINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 102. ARGENTINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 103. ARGENTINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 104. ARGENTINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 105. ARGENTINA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 106. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 107. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 108. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 109. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 110. REST OF SOUTH AMERICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 111. MEA NEEDLE-FREE INJECTION MARKET ANALYSIS

FIGURE 112. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 113. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 114. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 115. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 116. GCC COUNTRIES NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 117. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 118. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 119. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 120. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 121. SOUTH AFRICA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 122. REST OF MEA NEEDLE-FREE INJECTION MARKET ANALYSIS BY APPLICATION

FIGURE 123. REST OF MEA NEEDLE-FREE INJECTION MARKET ANALYSIS BY TECHNOLOGY

FIGURE 124. REST OF MEA NEEDLE-FREE INJECTION MARKET ANALYSIS BY END USE

FIGURE 125. REST OF MEA NEEDLE-FREE INJECTION MARKET ANALYSIS BY DOSAGE FORM

FIGURE 126. REST OF MEA NEEDLE-FREE INJECTION MARKET ANALYSIS BY REGIONAL

FIGURE 127. KEY BUYING CRITERIA OF NEEDLE-FREE INJECTION MARKET

FIGURE 128. RESEARCH PROCESS OF MRFR

FIGURE 129. DRO ANALYSIS OF NEEDLE-FREE INJECTION MARKET

FIGURE 130. DRIVERS IMPACT ANALYSIS: NEEDLE-FREE INJECTION MARKET

FIGURE 131. RESTRAINTS IMPACT ANALYSIS: NEEDLE-FREE INJECTION MARKET

FIGURE 132. SUPPLY / VALUE CHAIN: NEEDLE-FREE INJECTION MARKET

FIGURE 133. NEEDLE-FREE INJECTION MARKET, BY APPLICATION, 2024 (% SHARE)

FIGURE 134. NEEDLE-FREE INJECTION MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)

FIGURE 135. NEEDLE-FREE INJECTION MARKET, BY TECHNOLOGY, 2024 (% SHARE)

FIGURE 136. NEEDLE-FREE INJECTION MARKET, BY TECHNOLOGY, 2019 TO 2032 (USD Billions)

FIGURE 137. NEEDLE-FREE INJECTION MARKET, BY END USE, 2024 (% SHARE)

FIGURE 138. NEEDLE-FREE INJECTION MARKET, BY END USE, 2019 TO 2032 (USD Billions)

FIGURE 139. NEEDLE-FREE INJECTION MARKET, BY DOSAGE FORM, 2024 (% SHARE)

FIGURE 140. NEEDLE-FREE INJECTION MARKET, BY DOSAGE FORM, 2019 TO 2032 (USD Billions)

FIGURE 141. NEEDLE-FREE INJECTION MARKET, BY REGIONAL, 2024 (% SHARE)

FIGURE 142. NEEDLE-FREE INJECTION MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)

FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS